Design, Optimization, and Evaluation of Nanoemulsion-Based Drug Delivery Systems Incorporating Poorly Water-Soluble Antifungal Agents for Improved Solubility, Stability, and Therapeutic Efficacy in Topical Applications

Samaira Menon ,Dr. Niharika Vashisht

Department of Pharmaceutics and Nanomedicine, Amrita Vishwa Vidyapeetham (School of Nanosciences and Molecular Medicine), Kochi

1. Abstract

Fungal skin infections are increasingly becoming a significant global health issue, impacting millions and leading to increased morbidity, reduced quality of life, and escalating healthcare expenses. Traditional topical antifungal treatments like creams, ointments, and lotions often face challenges such as inadequate drug solubility, limited skin penetration, instability, and less than ideal therapeutic results. Many commonly used antifungal medications, such as azoles and allylamines, fall under Biopharmaceutics Classification System (BCS) class II or IV, which are characterized by poor water solubility and inconsistent bioavailability. These challenges call for innovative drug delivery methods that can improve solubility, stability, and localized therapeutic effectiveness while reducing systemic side effects.

Nanoemulsion-based drug delivery systems have gained attention as effective carriers for drugs with low water solubility due to their small droplet size (20–200 nm), large surface area, thermodynamic stability, and improved permeation characteristics. Nanoemulsions can dissolve lipophilic antifungal agents within their oil phase and enable controlled release through the skin barrier. Moreover, the addition of surfactants and co-surfactants enhances drug dissolution, thermodynamic stability, and skin penetration, leading to better therapeutic outcomes.

This research article thoroughly examines the design, optimization, and evaluation of nanoemulsion-based delivery systems that incorporate poorly water-soluble antifungal agents for topical use. It covers formulation strategies, physicochemical characterization, in vitro and ex vivo evaluation, and assessment of therapeutic efficacy. The paper integrates recent advancements in nanotechnology and pharmaceutics, including the construction of pseudo-ternary phase diagrams, high-pressure homogenization, and quality-by-design (QbD) optimization techniques. Additionally, it critically analyzes the mechanisms behind improved drug permeation, antifungal effectiveness, and stability enhancement.

Recent studies indicate that nanoemulsion formulations significantly improve solubility, drug loading, stability, skin permeation, and antifungal activity compared to traditional formulations. Optimized nanoemulsions exhibit smaller droplet sizes (<100 nm), a narrow polydispersity index, high zeta potential, and enhanced drug release profiles. Furthermore, ex vivo permeation and in vitro antifungal tests confirm superior drug penetration and increased activity against common fungal pathogens like Candida albicans and Trichophyton rubrum.

In summary, nanoemulsion-based topical delivery systems offer a highly effective approach to overcoming the solubility challenges of antifungal agents and enhancing therapeutic efficacy. This article provides a comprehensive research-oriented framework for designing optimized nanoemulsion formulations and outlines future opportunities in the field of topical antifungal nanomedicine.

2. Keywords

Antifungal medications; Nanoemulsion; Drugs with low water solubility; Delivery of drugs through the skin; Improvement of solubility; Stability; Penetration through the skin; Nanoemulgel; Effectiveness of treatment; Nanotechnology.